An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

Objective: Previous studies have demonstrated synergistic antitumor effects of angiotensin system inhibition (ASI) combined with cisplatin therapy in pancreatic cancer. This study examines whether or not synergistic antitumor effects occur with combination ASI and cisplatin treatment in lung cancer,...

Full description

Bibliographic Details
Main Authors: Hexiao Tang, MD, PhD, Eric Abston, MD, PhD, Mozhdeh Sojoodi, PhD, Yongtao Wang, PhD, Derek J. Erstad, MD, Zenan Lin, MD, Bryan C. Fuchs, PhD, Kenneth K. Tanabe, MD, Michael Lanuti, MD
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:JTCVS Open
Subjects:
losartan
lung cancer
epithelial-mesenchymal transition
cisplatin
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273624000159

Internet

http://www.sciencedirect.com/science/article/pii/S2666273624000159

Similar Items